Nederfors T, Dahlöf C
Department of Clinical Pharmacology, Sahlgrenska Hospital, University of Gothenburg, Sweden.
Arch Oral Biol. 1992;37(7):579-84. doi: 10.1016/0003-9969(92)90141-t.
The effects of beta-adrenoceptor antagonists on salivary secretion have been extensively studied in animals but not in man. The aim here was to compare salivary flow rate and composition in man during 1 week of treatment with a non-selective (propranolol 80 mg b.i.d.) and a beta 1-selective (atenolol 50 mg o.d.) antagonist with that of placebo. The randomized, double-blind, cross-over ("Latin square") design was used and 42 healthy male volunteers were recruited to the study. The treatment periods were separated by a wash-out period of 2 weeks. Whole saliva was sampled on day 0 (before) and on day 7 during each treatment. The plasma concentration of propranolol and atenolol was determined from blood samples obtained on day 7. Resting saliva was assessed for flow rate, amylase activity and concentration of total protein, hexosamine and sialic acid. Stimulated saliva was assessed for flow rate, pH, buffer pH, amylase activity and concentration of total protein, Ca2+, Mg2+, Na+, K+, Cl- and PO4(2-). In resting as well as stimulated whole saliva both the total protein concentration and the amylase activity were significantly decreased during the active treatment periods (p less than 0.05-p less than 0.001). At lunchtime during atenolol treatment the hexosamine/total protein and the sialic acid/total protein ratios were significantly increased (p less than 0.05-p less than 0.01), suggesting a possible effect on protein synthesis. In addition, the concentrations of Ca2+, PO4(2-), Cl- and Mg2+ were significantly altered during the active treatment periods (p less than 0.05-p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)
β-肾上腺素能受体拮抗剂对唾液分泌的影响已在动物中得到广泛研究,但在人类中尚未有相关研究。本研究的目的是比较非选择性(普萘洛尔80毫克,每日两次)和β1选择性(阿替洛尔50毫克,每日一次)拮抗剂治疗1周期间与安慰剂相比,人类的唾液流速和成分。采用随机、双盲、交叉(“拉丁方”)设计,招募了42名健康男性志愿者参与研究。治疗期之间间隔2周的洗脱期。在每个治疗阶段的第0天(治疗前)和第7天采集全唾液样本。从第7天采集的血样中测定普萘洛尔和阿替洛尔的血浆浓度。对静息唾液的流速、淀粉酶活性以及总蛋白、氨基己糖和唾液酸的浓度进行评估。对刺激唾液的流速、pH值、缓冲pH值、淀粉酶活性以及总蛋白、Ca2+、Mg2+、Na+、K+、Cl-和PO4(2-)的浓度进行评估。在静息和刺激的全唾液中,活性治疗期内总蛋白浓度和淀粉酶活性均显著降低(p<0.05 - p<0.001)。在阿替洛尔治疗期间的午餐时间,氨基己糖/总蛋白和唾液酸/总蛋白比值显著升高(p<0.05 - p<0.01),提示可能对蛋白质合成有影响。此外,活性治疗期内Ca2+、PO4(2-)、Cl-和Mg2+的浓度也发生了显著变化(p<0.05 - p<0.001)。(摘要截选至250字)